Ulrich H. Van Oy-Hofstadt
Dortmund, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Muscle Regeneration Failure May Lead to Clinical Features of Myopathy in Anti-IgLON5 Disease.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 13, 2026
Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis.
Journal: Brain : a journal of neurology
Published: December 28, 2021
Clinical, serological and genetic predictors of response to immunotherapy in anti-IgLON5 disease.
Journal: Brain : a journal of neurology
Published: September 13, 2021
Complement inhibition initiated recovery of a severe myasthenic crisis with COVID-19.
Journal: Journal of neurology
Published: January 12, 2021
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: A cohort study from Germany.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: June 02, 2020
Apheresis therapies for NMOSD attacks: A retrospective study of 207 therapeutic interventions.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: May 03, 2018
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: January 08, 2017
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 21, 2016
Very late-onset neuromyelitis optica spectrum disorder beyond the age of 75.
Journal: Journal of neurology
Published: March 17, 2015
Dynamic walking features and improved walking performance in multiple sclerosis patients treated with fampridine (4-aminopyridine).
Journal: BMC neurology
Published: March 17, 2015
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses.
Journal: Annals of neurology
Published: February 24, 2015
Last Updated: 09/26/2026